Courage Over Cancer

Welcome our new Registered Dietitians

Early detection is key: The importance of colorectal cancer screenings

Study results show immunotherapy before and after surgery for advanced melanoma lowers recurrence risk

  Mays Cancer Center at UT Health San Antonio melanoma expert Monte Shaheen, MD, was part of a team of investigators that conducted a phase II clinical trial funded by the National Cancer Institute (NCI) to determine the efficacy and safety of administering the immunotherapy drug pembrolizumab before and after surgery in high-risk melanoma patients. […]

Amelie Ramirez named to San Antonio Women’s Hall of Fame

  Amelie Ramirez, DrPH, MPH, leader of Salud America! at UT Health San Antonio, is among 15 new inductees to the San Antonio Women’s Hall of Fame. The San Antonio Women’s Hall of Fame has annually inducted women from Bexar and surrounding counties who have shaped the future of San Antonio and paved the way for women […]

KSAT 12: Lymphedema Treatment Act will cover what health insurance doesn’t

Anton Fries, MD, PhD, chief, Division of Plastic and Reconstructive Surgery, was interviewed for this news segment.   Watch Now

Mays Cancer Center led studies of innovative breast cancer drug that recently gained FDA approval

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer. The U.S. Food and Drug Administration on Jan. 27 announced it approved the […]